The Board of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. announced Mr. ZHAO Dayao was appointed as an independent non-executive Director of the Company with effect from 11 October 2019 and until the expiration of the term of the current session of the Board. At the same time, Mr. Zhao was also appointed as the chairman of the nomination committee of the Board and a member of the audit committee of the Board with effect from the same date. The biographical details of Mr. Zhao and his information which was required to be disclosed pursuant to Rule 13.51(2) of the Listing Rules were set out in the announcement of the Company dated 17 September 2019. And also announced that Mr. LEE Chi Ming resigned from his positions as an independent non-executive Director of the Company, the chairman of the nomination committee of the Board and a member of the audit committee of the Board due to health and work reasons with effect from 11 October 2019. He has confirmed that he has no disagreement with the Board. In addition, there is no other matters in relation to the resignation of Mr. Lee that needed to be brought to the attention of the Shareholders. The Board would like to take this opportunity to express its sincere gratitude to Mr. Lee for his contribution to the Company during the tenure of his service.